Harvard Bioscience
HBIO
HBIO
78 hedge funds and large institutions have $48.7M invested in Harvard Bioscience in 2019 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 27 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
60% less capital invested
Capital invested by funds: $121M → $48.7M (-$72.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
78
Holding in Top 10
–
Calls
$3K
Puts
–
Top Buyers
| 1 | +$3.74M | |
| 2 | +$2.13M | |
| 3 | +$1.98M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$653K |
| 5 |
FM
Fondren Management
Houston,
Texas
|
+$618K |
Top Sellers
| 1 | -$13M | |
| 2 | -$3.06M | |
| 3 | -$1.51M | |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$1.02M |
| 5 |
State Street
Boston,
Massachusetts
|
-$969K |